| 1 |
Vaz SH, Pinto S, Sebastião AM, Brites D. Astrocytes in Amyotrophic Lateral Sclerosis. In: Araki T, editor. Amyotrophic Lateral Sclerosis. Exon Publications; 2021. pp. 35-54. [DOI: 10.36255/exonpublications.amyotrophiclateralsclerosis.astrocytes.2021] [Reference Citation Analysis]
|
| 2 |
Jensen BK, McAvoy KJ, Heinsinger NM, Lepore AC, Ilieva H, Haeusler AR, Trotti D, Pasinelli P. Targeting TNFα produced by astrocytes expressing amyotrophic lateral sclerosis-linked mutant fused in sarcoma prevents neurodegeneration and motor dysfunction in mice. Glia 2022;70:1426-49. [PMID: 35474517 DOI: 10.1002/glia.24183] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Sugiyama K, Tanaka K. Spinal cord-specific deletion of the glutamate transporter GLT1 causes motor neuron death in mice. Biochemical and Biophysical Research Communications 2018;497:689-93. [DOI: 10.1016/j.bbrc.2018.02.132] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 4 |
Manochkumar J, Doss CGP, El-Seedi HR, Efferth T, Ramamoorthy S. The neuroprotective potential of carotenoids in vitro and in vivo. Phytomedicine 2021;91:153676. [PMID: 34339943 DOI: 10.1016/j.phymed.2021.153676] [Reference Citation Analysis]
|
| 5 |
Malik AR, Willnow TE. Excitatory Amino Acid Transporters in Physiology and Disorders of the Central Nervous System. Int J Mol Sci 2019;20:E5671. [PMID: 31726793 DOI: 10.3390/ijms20225671] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 6 |
Liu Z, Zhou T, Ziegler AC, Dimitrion P, Zuo L. Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications. Oxid Med Cell Longev 2017;2017:2525967. [PMID: 28785371 DOI: 10.1155/2017/2525967] [Cited by in Crossref: 268] [Cited by in F6Publishing: 258] [Article Influence: 53.6] [Reference Citation Analysis]
|
| 7 |
Fontana ACK. Current approaches to enhance glutamate transporter function and expression. J Neurochem 2015;134:982-1007. [DOI: 10.1111/jnc.13200] [Cited by in Crossref: 83] [Cited by in F6Publishing: 79] [Article Influence: 11.9] [Reference Citation Analysis]
|
| 8 |
Martinez-Lozada Z, Guillem AM, Robinson MB. Transcriptional Regulation of Glutamate Transporters: From Extracellular Signals to Transcription Factors. Adv Pharmacol 2016;76:103-45. [PMID: 27288076 DOI: 10.1016/bs.apha.2016.01.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 9 |
Pehar M, Harlan BA, Killoy KM, Vargas MR. Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral Sclerosis. Curr Pharm Des 2017;23:5010-21. [PMID: 28641533 DOI: 10.2174/1381612823666170622095802] [Cited by in Crossref: 15] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 10 |
Rosenblum LT, Shamamandri-Markandaiah S, Ghosh B, Foran E, Lepore AC, Pasinelli P, Trotti D. Mutation of the caspase-3 cleavage site in the astroglial glutamate transporter EAAT2 delays disease progression and extends lifespan in the SOD1-G93A mouse model of ALS. Exp Neurol 2017;292:145-53. [PMID: 28342750 DOI: 10.1016/j.expneurol.2017.03.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 11 |
Valori CF, Guidotti G, Brambilla L, Rossi D. Astrocytes in Motor Neuron Diseases. Adv Exp Med Biol 2019;1175:227-72. [PMID: 31583591 DOI: 10.1007/978-981-13-9913-8_10] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 12 |
Ohgomori T, Yamasaki R, Takeuchi H, Kadomatsu K, Kira JI, Jinno S. Differential involvement of vesicular and glial glutamate transporters around spinal α-motoneurons in the pathogenesis of SOD1G93A mouse model of amyotrophic lateral sclerosis. Neuroscience 2017;356:114-24. [PMID: 28526579 DOI: 10.1016/j.neuroscience.2017.05.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 13 |
Hayashi Y, Homma K, Ichijo H. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS. Adv Biol Regul 2016;60:95-104. [PMID: 26563614 DOI: 10.1016/j.jbior.2015.10.006] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 14 |
Jordan K, Murphy J, Singh A, Mitchell CS. Astrocyte-Mediated Neuromodulatory Regulation in Preclinical ALS: A Metadata Analysis. Front Cell Neurosci 2018;12:491. [PMID: 30618638 DOI: 10.3389/fncel.2018.00491] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 15 |
King AE, Woodhouse A, Kirkcaldie MT, Vickers JC. Excitotoxicity in ALS: Overstimulation, or overreaction? Experimental Neurology 2016;275:162-71. [DOI: 10.1016/j.expneurol.2015.09.019] [Cited by in Crossref: 80] [Cited by in F6Publishing: 81] [Article Influence: 13.3] [Reference Citation Analysis]
|
| 16 |
Mathis S, Goizet C, Soulages A, Vallat JM, Masson GL. Genetics of amyotrophic lateral sclerosis: A review. J Neurol Sci 2019;399:217-26. [PMID: 30870681 DOI: 10.1016/j.jns.2019.02.030] [Cited by in Crossref: 79] [Cited by in F6Publishing: 72] [Article Influence: 26.3] [Reference Citation Analysis]
|
| 17 |
Armada-Moreira A, Gomes JI, Pina CC, Savchak OK, Gonçalves-Ribeiro J, Rei N, Pinto S, Morais TP, Martins RS, Ribeiro FF, Sebastião AM, Crunelli V, Vaz SH. Going the Extra (Synaptic) Mile: Excitotoxicity as the Road Toward Neurodegenerative Diseases. Front Cell Neurosci 2020;14:90. [PMID: 32390802 DOI: 10.3389/fncel.2020.00090] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
|
| 18 |
Rosenblum LT, Trotti D. EAAT2 and the Molecular Signature of Amyotrophic Lateral Sclerosis. Adv Neurobiol 2017;16:117-36. [PMID: 28828608 DOI: 10.1007/978-3-319-55769-4_6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
|
